logo
Plus   Neg
Share
Email

Zyus Life Sciences Gets Health Canada Medical Sales License

Zyus Life Sciences Inc. said that it received a medical sales license from Health Canada, effective July 31.

The Canada-based company noted that the medical sales license allows it to enroll medical cannabis patients as it works to advance the development, formulation, and application of phyto-therapeutics.

Zyus was launched in 2018 by Canadian medical cannabis pioneer Brent Zettl. The company aims to innovate the use of cannabinoids in healthcare.

Over the past year, Zyus has received its processing, analytical testing and research licenses from Health Canada, strengthened its leadership team, and launched pre-clinical trials to determine the impact of cannabis derivatives on mental and neurological health conditions.

The company has also successfully achieved plant-made expression, isolation and purification of a potential antigen for a SARS-CoV-2 vaccine. In July, Zyus said that its preliminary research results showed that plant-based antigens are reactive to anti-COVID-19 antibodies and potentially offer immunity from COVID-19.

Following the receipt of its medical sales license, Zyus said it will now apply to Health Canada to amend its processing license to add cannabis extracts and topical formulations to the license. This will enable the company to facilitate sale of cannabinoid-based oil, gel-cap and topical formulations.

Zyus plans to launch sales and distribute its oil formulations directly to registered patients in the second half of 2020.

To ensure a consistent supply of formulations for registered medical patients, operations are currently underway at Zyus' Saskatoon Phase I, GMP designed processing facility. Zyus said it remains on track to complete the development and construction of Phase II of the processing facility by the end of 2020.

Zyus said it is now accepting patient enrollments via phone, and will launch online patient enrollment on its website in the coming weeks.

For comments and feedback contact: editorial@rttnews.com

Health News

Follow RTT